Skip to content

In the BioHarmony Drug Report Database


Dapiprazole, Abilify (dapiprazole) is a small molecule pharmaceutical. Dapiprazole was first approved as Dapiprazole on 1990-12-31. It is used to treat mydriasis in the USA. It has been approved in Europe to treat bipolar disorder and schizophrenia. The pharmaceutical is active against alpha-1D adrenergic receptor.
Trade Name Abilify, Abilify Maintena
Common Name Dapiprazole
Indication bipolar disorder, mydriasis, schizophrenia
Drug Class Antiulcer agents (benzimidazole derivatives)
Get full access now